TransMedics Group Inc (TMDX) support and resistance · P/E 17, rev $363.9M
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
This page maps TransMedics Group Inc (TMDX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
TMDX currently screens at market cap $2.53B and trailing P/E 16.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TMDX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TMDX quote page for the session range and the stock page for the full model.
Not investment advice.